Hutchison China MediTech Limited Sponsored ADR Stock
Hutchison China MediTech Limited Sponsored ADR Stock price
Key metrics
| Market capitalization | $2.92b |
| Enterprise Value | $2.21b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 3.58 |
| P/S ratio (TTM) P/S ratio | 4.73 |
| P/B ratio (TTM) P/B ratio | 3.94 |
| Revenue growth (TTM) Revenue growth | -19.35% |
| Revenue (TTM) Revenue | $617.39m |
Is Hutchison China MediTech Limited Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Hutchison China MediTech Limited Sponsored ADR Stock Analysis
Analyst Opinions
11 Analysts have issued a Hutchison China MediTech Limited Sponsored ADR forecast:
Analyst Opinions
11 Analysts have issued a Hutchison China MediTech Limited Sponsored ADR forecast:
Financial data from Hutchison China MediTech Limited Sponsored ADR
| Jun '24 |
+/-
%
|
||
| Revenue | 617 617 |
19%
19%
|
|
| Gross Profit | 257 257 |
32%
32%
|
|
| EBITDA | -112 -112 |
13%
13%
|
EBIT (Operating Income) EBIT | -123 -123 |
15%
15%
|
| Net Profit | -43 -43 |
18%
18%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Hutchison China MediTech Limited Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Hutchison China MediTech Limited Sponsored ADR Stock News
Company Profile
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. The Commercial Platform segment relates to prescription drugs which develops, manufacture, markets, and sale of prescription pharmaceuticals; and consumer health which comprised of development, manufacture, distribution, and marketing of over-the-counter pharmaceuticals, and consumer health products. The company was founded in June 2000 and is headquartered in Hong Kong.
| Head office | Cayman Islands |
| CEO | Wei Su |
| Employees | 1,988 |
| Founded | 2000 |
| Website | www.hutch-med.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
